Hollencrest Capital Management’s Novartis NVS Stock Holding History

Hollencrest Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13K	Sell	20 -112	-85%	-$16.8K	﹤0.01%	976
2026 Q1	$20.2K	Hold	132	–	–	﹤0.01%	720
2025 Q4	$18.2K	Sell	132 -100	-43%	-$13.1K	﹤0.01%	729
2025 Q3	$29.8K	Hold	232	–	–	﹤0.01%	643
2025 Q2	$28.1K	Hold	232	–	–	﹤0.01%	616
2025 Q1	$25.9K	Hold	232	–	–	﹤0.01%	629
2024 Q4	$22.6K	Hold	232	–	–	﹤0.01%	674
2024 Q3	$26.7K	Hold	232	–	–	﹤0.01%	614
2024 Q2	$24.7K	Hold	232	–	–	﹤0.01%	626
2024 Q1	$22.4K	Hold	232	–	–	﹤0.01%	612
2023 Q4	$23.4K	Hold	232	–	–	﹤0.01%	609
2023 Q3	$23.6K	Hold	232	–	–	﹤0.01%	594
2023 Q2	$23.4K	Hold	232	–	–	﹤0.01%	629
2023 Q1	$21.3K	Hold	232	–	–	﹤0.01%	634
2022 Q4	$21K	Buy	+232	New	+$19.5K	﹤0.01%	602
2016 Q1	–	Sell	-6,819	Closed	-$526K	–	413
2015 Q4	$526K	Sell	6,819 -167	-2%	-$13.3K	0.09%	181
2015 Q3	$575K	Buy	6,986 +4,687	+204%	+$417K	0.1%	143
2015 Q2	$203K	Buy	+2,299	New	+$211K	0.03%	361

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hollencrest Capital Management's NVS Position: Q2 2026 in Review

Hollencrest Capital Management reduced its Novartis (NVS) stake by 85% in Q2 2026, selling an estimated $16.8K and leaving 20 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Hollencrest Capital Management first reported a position in NVS in Q2 2015 and has held it in 18 quarters since. The position peaked at $575K in Q3 2015. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Hollencrest Capital Management held 20 shares of Novartis worth $3.13K as of Q2 2026.
Hollencrest Capital Management sold 112 Novartis shares in Q2 2026, an estimated $16.8K.
Novartis made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #976 holding.
Hollencrest Capital Management first reported a position in Novartis in Q2 2015 and has held it in 18 quarters since.
Hollencrest Capital Management's Novartis position peaked at $575K in Q3 2015.
1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.